UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the month of February 2022 for the period ended December 31, 2021

001-41208

(Commission File Number)

NOVONIX LIMITED

(Translation of registrant’s name into English)

Level 8

46 Edward Street

Brisbane, QLD 4000

Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40‑F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

EXHIBIT INDEX

Exhibit No.	Description
Exhibit 99.1	Corporate directory
Exhibit 99.2	Review of operations and activities for the half year ended December 31, 2021
Exhibit 99.3	Directors’ Report
Exhibit 99.4	Auditor’s Independence Declaration
Exhibit 99.5	Consolidated interim financial statements for the half year ended December 31, 2021
Exhibit 99.6	Directors’ Declaration
Exhibit 99.7	Preparation of interim financial statements for users in multiple jurisdictions
Exhibit 99.8	Independent Auditor’s Review Report
Exhibit 99.9	Appendix 4D

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NOVONIX LIMITED
By:	/s/ Robert J. Natter
	Robert J. Natter
	Chairman
NOVONIX LIMITED
By:	/s/ Suzanne Yeates
	Suzanne Yeates
	Corporate Secretary

Date: February 1, 2022